# Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

> **NCT00194792** · PHASE2 · TERMINATED · sponsor: **University of Washington** · enrollment: 28 (actual)

## Conditions studied

- Estrogen Receptor-positive Breast Cancer
- HER2-negative Breast Cancer
- Progesterone Receptor-positive Breast Cancer
- Stage I Breast Cancer
- Stage II Breast Cancer
- Stage IIIA Breast Cancer

## Interventions

- **DRUG:** exemestane
- **DRUG:** triptorelin pamoate
- **DRUG:** capecitabine
- **DRUG:** methotrexate
- **DRUG:** vinorelbine tartrate
- **DRUG:** paclitaxel
- **PROCEDURE:** therapeutic conventional surgery
- **RADIATION:** radiation therapy
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00194792
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-08
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00194792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00194792, "Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00194792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*